Hangzhou Cancer Hospital
In research, Hangzhou Cancer Hospital stands highest in Medicine (#2,814 of 10,443 worldwide), Life Sciences (#2,441 of 7,800 worldwide) and Health Sciences (#3,814 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 14.2× its share of world research.
- World rank, 2022–2025
- #5,225 of 28,054 · #12,912 all time
- Rank in China
- #1,131 of 3,058
- Research works
- 681 ▲ 32% vs 2013–17
- Citations
- 7.4k 10.8 per fractional work
- Top-10% rate
- 19.7% record average 16.5%
- Open access
- 54% world 28%
What is Hangzhou Cancer Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #2,814 of 10,443 | 18.3% | 180 | #7073 | |
| Life SciencesDomain | #2,441 of 7,800 | 22.0% | 88 | #6072 | |
| Health SciencesDomain | #3,814 of 11,982 | 18.2% | 183 | #9186 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,004 of 3,579 | 19.3% | 70 | #6315 |
Each strip is that field’s whole ranked pool, with the notch where Hangzhou Cancer Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#7,073 #2,814
- Life Sciences#6,072 #2,441
- Health Sciences#9,186 #3,814
- Biochemistry, Genetics and Molecular Biology#6,315 #3,004
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Hangzhou Cancer Hospital specialise in?
Where its research is concentrated relative to its size: Oncology takes 14.2× the share of its output that it takes of world research.
- OncologySubfield · 46.8 works14×
- Pulmonary and Respiratory MedicineSubfield · 36.2 works8.1×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.5×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.5×
- Immunology and Microbiology 4.1×
- Medicine 3.2×
- Pharmacology, Toxicology and Pharmaceutics 1.9×
- Dentistry 0.7×
- Neuroscience 0.5×
- Physics and Astronomy 0.3×
- Chemistry 0.3×
- Materials Science 0.2×
- Health Professions 0.2×
- Chemical Engineering 0.2×
- Engineering 0.2×
- Nursing 0.2×
- Economics, Econometrics and Finance 0.2×
- Computer Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Mathematics 0.1×
- Psychology 0.1×
- Environmental Science 0.0×
- Energy 0.0×
- Arts and Humanities 0.0×
- Social Sciences 0.0×
Who are the top researchers at Hangzhou Cancer Hospital?
Ranked on the composite score, Shixiu Wu and Qiang Hou lead among researchers whose main affiliation is Hangzhou Cancer Hospital.
- 1 Shixiu Wu China · #716,485 worldwide 44 citations · 21 works
- 2 Qiang Hou China · #1,548,835 worldwide 8 citations · 15 works
Which keywords describe research at Hangzhou Cancer Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Chemotherapy, Tumor Microenvironment, Immunotherapy, Targeted Therapy, Clinical Trials, Prognostic Factors and Metastasis.
- Lipid Peroxidation
- Epigenetic Regulation
- Surgery
- Small-Cell Lung Cancer
- Biogenesis
- Tumor Markers
- Apoptosis
- Cancer Therapy
- EGFR Mutations
- Survival Analysis
- Treatment Guidelines
- Cell Death
- PD-1 and PD-L1
- Clinical Practice Guidelines
- Gene Expression
- Biomarkers
- Prognostic Factors
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Cancer
- Tumor Microenvironment
- Inflammation
- Clinical Trials
- Metastasis
- Oxidative Stress
- Radiotherapy
- Immune Checkpoint Blockade
- Immunity
- Neoadjuvant Therapy
- Genomic Profiling
- ALK Inhibitors
- Endoscopic Resection
- Precision Medicine
- Regulation
- Adjuvant Therapy
- Genomic Profiles
- Breast Cancer
- Cancer Progression
- Molecular Characterization
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer44▲ 11×47 topics
- Chemotherapy32▲ 16×21 topics
- Tumor Microenvironment28▲ 21×8 topics
- Immunotherapy24▲ 11×16 topics
- Inflammation22▲ 3.6×58 topics
- Targeted Therapy20▲ 31×5 topics
- Clinical Trials19▲ 9.9×12 topics
- Prognostic Factors16▲ 13×13 topics
- Metastasis16▲ 16×11 topics
- Biomarkers15▲ 7.7×14 topics
- Oxidative Stress14▲ 3.0×34 topics
- Gene Expression13▲ 7.4×13 topics
- Radiotherapy13▲ 11×11 topics
- Clinical Practice Guidelines12▲ 7.7×12 topics
- Immune Checkpoint Blockade11▲ 35×1 topic
- PD-1 and PD-L111▲ 35×1 topic
- Immunity11▲ 9.3×7 topics
- Cell Death10▲ 15×6 topics
- Neoadjuvant Therapy10▲ 15×5 topics
- Treatment Guidelines10▲ 15×5 topics
- Genomic Profiling10▲ 32×2 topics
- Survival Analysis10▲ 12×6 topics
- ALK Inhibitors9▲ 51×1 topic
- EGFR Mutations9▲ 51×1 topic
- Endoscopic Resection9▲ 32×2 topics
- Cancer Therapy9▲ 5.5×15 topics
- Precision Medicine8▲ 6.2×7 topics
- Apoptosis8▲ 9.3×15 topics
- Regulation8▲ 5.1×9 topics
- Tumor Markers8▲ 34×2 topics
- Adjuvant Therapy8▲ 21×2 topics
- Biogenesis7▲ 14×3 topics
- Genomic Profiles7▲ 60×1 topic
- Small-Cell Lung Cancer7▲ 60×1 topic
- Breast Cancer7▲ 10×9 topics
- Surgery7▲ 6.8×7 topics
- Cancer Progression7▲ 12×7 topics
- Epigenetic Regulation7▲ 11×4 topics
- Molecular Characterization7▲ 13×5 topics
- Lipid Peroxidation6▲ 21×2 topics
Which research topics does Hangzhou Cancer Hospital publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Ferroptosis and cancer prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 11 works
- 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 9 works
- 3 Lung Cancer Research Studies Oncology 7 works
- 4 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 6 works
- 5 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 5 works
- 6 Esophageal Cancer Research and Treatment Surgery 5 works
- 7 RNA modifications and cancer Molecular Biology 4 works
- 8 Cancer-related molecular mechanisms research Cancer Research 4 works
- 9 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 4 works
- 10 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hangzhou Cancer Hospital's research output changed?
Output in 2018–2022 was 32% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hangzhou
- Zhejiang University
- Zhejiang University of Technology
- Hangzhou Dianzi University
- Zhejiang Sci-Tech University
- China Jiliang University
- Hangzhou Normal University
- Zhejiang Chinese Medical University
- Zhejiang Gongshang University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.